/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW./
CALGARY, AB, Dec. 3, 2024 /CNW/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel“) (TSXV: DB) (OTCQB: DBCCF), a market leader in premium cannabis and extract manufactured products, is pleased to announce that it has received final acceptance from the TSX Venture Exchange (the “TSXV“) for its previously announced acquisition of AgMedica Bioscience Inc. (“AgMedica“) on October 28, 2024 pursuant to an assignment agreement entered into with Callisto Capital Corp. (“Callisto“) in exchange for a $6.3 million unsecured convertible debenture (the “Convertible Debenture“). As a result of receiving the acceptance, Decibel has completed the conversion of the Convertible Debenture,…
